Suppr超能文献

卢旺达布塔雷大学教学医院收治的新冠肺炎成年患者的治疗结果及通用生命评估(UVA)死亡率风险评分的验证

Outcomes of adults hospitalized with COVID-19 at the University Teaching Hospital of Butare in Rwanda and validation of the Universal Vital Assessment (UVA) mortality risk score.

作者信息

Gashame Dona Fabiola, Boateng Kwame A Akuamoah, Twagirumukiza Jean Damascene, de Dieu Mahoro Jean, Moore Christopher C, Twagirumugabe Theogene

机构信息

Department of Anesthesia and Critical Care, Kigali University Teaching Hospital, University of Rwanda, Kigali, Rwanda.

Department of Surgery, Division of Acute Care Surgical Services, Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States of America.

出版信息

PLOS Glob Public Health. 2024 Dec 9;4(12):e0003695. doi: 10.1371/journal.pgph.0003695. eCollection 2024.

Abstract

There are few data regarding clinical outcomes from COVD-19 from low-income countries (LICs) including Rwanda. Accordingly, we aimed to determine 1) outcomes of patients admitted to hospital with COVID-19 in Rwanda, and 2) the ability of the Universal Vital Assessment (UVA) score to predict mortality in patients with COVID-19 compared to sequential organ failure assessment (SOFA) and quick (qSOFA) scores. We conducted a retrospective study of patients aged ≥18 years hospitalized with laboratory-confirmed COVID-19 at the University Teaching Hospital of Butare (CHUB), Rwanda, April 2021-January 2022. For each participant, we calculated UVA, SOFA, and qSOFA risk scores and determined their area under the receive operating characteristic curve (AUC). We used logistic regression to determine predictors of mortality. Of the 150 patients included, 83 (55%) were female and the median (IQR) age was 61 (43-73) years. The median (IQR) length of hospital stay was 6 (3-10) days. Respiratory failure occurred in 69 (46%) including 34 (23%) who had ARDS. The case fatality rate was 44%. Factors independently associated with mortality included acute kidney injury (adjusted odds ratio [aOR] 7.99, 95% confidence interval [CI] 1.47-43.22, p = 0.016), severe COVID-19 (aOR 3.42, 95% CI 1.06-11.01, p = 0.039), and a UVA score >4 (aOR 7.15, 95% CI 1.56-32.79, p = 0.011). The AUCs for UVA, qSOFA, and SOFA scores were 0.86 (95% CI 0.79-0.92), 0.81 (95% CI 0.74-0.88), and 0.84 (95% CI 0.78-0.91), respectively, which were not statistically significantly different from each other. At a UVA score cut-off of 4, the sensitivity, specificity, positive predictive value, and negative predictive value for mortality were 0.58, 0.93, 0.86, and 0.74, respectively. Patients hospitalized with COVID-19 in CHUB had high mortality, which was accurately predicted by the UVA score. Calculation of the UVA score in patients with COVID-19 in LICs may assist clinicians with triage and other management decisions.

摘要

关于包括卢旺达在内的低收入国家(LICs)中COVID - 19临床结果的数据很少。因此,我们旨在确定:1)卢旺达因COVID - 19住院患者的结局;2)与序贯器官衰竭评估(SOFA)和快速(qSOFA)评分相比,通用生命评估(UVA)评分预测COVID - 19患者死亡率的能力。我们对2021年4月至2022年1月在卢旺达布塔雷大学教学医院(CHUB)因实验室确诊的COVID - 19住院的≥18岁患者进行了一项回顾性研究。对于每位参与者,我们计算了UVA、SOFA和qSOFA风险评分,并确定了它们在接受操作特征曲线(AUC)下的面积。我们使用逻辑回归来确定死亡率的预测因素。在纳入的150名患者中,83名(55%)为女性,中位(四分位间距)年龄为61岁(43 - 73岁)。中位(四分位间距)住院时间为6天(3 - 10天)。69名(46%)患者发生呼吸衰竭,其中34名(23%)患有急性呼吸窘迫综合征(ARDS)。病死率为44%。与死亡率独立相关的因素包括急性肾损伤(调整后的优势比[aOR] 7.99,95%置信区间[CI] 1.47 - 43.22,p = 0.016)、重症COVID - 19(aOR 3.42,95% CI 1.06 - 11.01,p = 0.039)以及UVA评分>4(aOR 7.15,95% CI 1.56 - 32.79,p = 0.011)。UVA、qSOFA和SOFA评分的AUC分别为0.86(95% CI 0.79 - 0.92)、0.81(95% CI 0.74 - 0.88)和0.84(95% CI 0.78 - 0.91),它们之间在统计学上无显著差异。在UVA评分临界值为4时,死亡率的敏感性、特异性、阳性预测值和阴性预测值分别为0.58、0.93、0.86和0.74。在CHUB因COVID - 19住院的患者死亡率很高,UVA评分能准确预测。在低收入国家计算COVID - 19患者的UVA评分可能有助于临床医生进行分诊和其他管理决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaa5/11627434/bfd5ce8bf1f4/pgph.0003695.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验